InvestorsHub Logo
Followers 28
Posts 3276
Boards Moderated 0
Alias Born 01/04/2013

Re: None

Tuesday, 07/12/2022 7:45:42 AM

Tuesday, July 12, 2022 7:45:42 AM

Post# of 429204
Am I correct in assuming that because the control arm of MITIGATE receives no mineral oil or other placebo that if the study shows REDUCE-IT like benefits it may reinforce the value of Vascepa and put to rest the MO controversy?

All it takes for evil to prevail is for a few good men to do nothing.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News